Analysts Are Bullish on These Healthcare Stocks: Sanuwave Health (SNWV), PROCEPT BioRobotics (PRCT)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sanuwave Health (SNWV – Research Report), PROCEPT BioRobotics (PRCT – Research Report) and Scholar Rock Holding (SRRK – Research Report) with bullish sentiments.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sanuwave Health (SNWV)
Northland Securities analyst Carl Byrnes maintained a Buy rating on Sanuwave Health today and set a price target of $55.00. The company’s shares closed last Monday at $21.89, close to its 52-week low of $18.50.
According to TipRanks.com, Byrnes is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Sanuwave Health has an analyst consensus of Moderate Buy, with a price target consensus of $54.00.
See the top stocks recommended by analysts >>
PROCEPT BioRobotics (PRCT)
In a report released today, Brandon Vazquez from William Blair maintained a Buy rating on PROCEPT BioRobotics. The company’s shares closed last Monday at $27.62.
According to TipRanks.com, Vazquez is ranked 0 out of 5 stars with an average return of
PROCEPT BioRobotics has an analyst consensus of Moderate Buy, with a price target consensus of $35.22, representing a 29.8% upside. In a report issued on March 2, Piper Sandler also maintained a Buy rating on the stock with a $28.00 price target.
Scholar Rock Holding (SRRK)
In a report released today, Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Scholar Rock Holding. The company’s shares closed last Monday at $40.45, close to its 52-week high of $46.98.
According to TipRanks.com, Ahmad is a 2-star analyst with an average return of
Scholar Rock Holding has an analyst consensus of Strong Buy, with a price target consensus of $56.50, which is a 40.3% upside from current levels. In a report issued on March 5, TipRanks – Google also upgraded the stock to Buy with a $53.00 price target.
